Chan WY, Al-Yousuf H, Lam HPJ, Leong S, et al. Real-world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS-like tyrosine kinase 3 (FLT3)-mutated relapsed/refractory acute myeloid leukaemia: A UK single-centre experience. Br J Haematol 2026;209:1386-1390.
PMID: 42472641